Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial peroxidases and related redox enzymes, most notably the catalase-peroxidase KatG, are critical components of the bacterial defense system against oxidative stress. These enzymes catalyze the decomposition of hydrogen peroxide and other reactive oxygen species, protecting the pathogen from host-mediated immune attacks. In the context of pharmacology, KatG is uniquely significant as the primary activator of the frontline anti-tuberculosis drug Isoniazid. Mutations in the genes encoding these enzymes, particularly katG, are the most common mechanism of high-level resistance in Mycobacterium tuberculosis. Beyond KatG, related enzymes like alkyl hydroperoxide reductase (AhpC) often compensate for the loss of peroxidase activity in resistant strains, maintaining bacterial viability under stress.
Isoniazid is a prodrug that must be activated by the bacterial catalase-peroxidase enzyme (KatG) to form an isonicotinyl-NAD adduct, which then inhibits InhA (enoyl-ACP reductase), blocking mycolic acid synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial peroxidase and related bacterial redox enzymes (KatG/AhpC).